These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 31672631)

  • 1. Combined application of angiotensin converting enzyme and chitotriosidase analysis improves the laboratory diagnosis of sarcoidosis.
    Enyedi A; Csongrádi A; Altorjay IT; Beke GL; Váradi C; Enyedi EE; Kiss DR; Bányai E; Kalina E; Kappelmayer J; Tóth A; Papp Z; Takács I; Fagyas M
    Clin Chim Acta; 2020 Jan; 500():155-162. PubMed ID: 31672631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic Value of Serum-Soluble Interleukin 2 Receptor Levels vs Angiotensin-Converting Enzyme in Patients With Sarcoidosis-Associated Uveitis.
    Groen-Hakan F; Eurelings L; ten Berge JC; van Laar J; Ramakers CRB; Dik WA; Rothova A
    JAMA Ophthalmol; 2017 Dec; 135(12):1352-1358. PubMed ID: 29121154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum soluble interleukin-2 receptor level is more sensitive than angiotensin-converting enzyme or lysozyme for diagnosis of sarcoidosis and may be a marker of multiple organ involvement.
    Thi Hong Nguyen C; Kambe N; Kishimoto I; Ueda-Hayakawa I; Okamoto H
    J Dermatol; 2017 Jul; 44(7):789-797. PubMed ID: 28295528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chitotriosidase as a marker of disease activity in sarcoidosis.
    Brunner J; Scholl-Bürgi S; Zimmerhackl LB
    Rheumatol Int; 2007 Oct; 27(12):1171-2. PubMed ID: 17534622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitivity and specificity of serum soluble interleukin-2 receptor for diagnosing sarcoidosis in a population of patients suspected of sarcoidosis.
    Eurelings LEM; Miedema JR; Dalm VASH; van Daele PLA; van Hagen PM; van Laar JAM; Dik WA
    PLoS One; 2019; 14(10):e0223897. PubMed ID: 31622413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chitotriosidase as a marker of disease activity in sarcoidosis.
    Brunner J; Scholl-Bürgi S; Prelog M; Zimmerhackl LB
    Rheumatol Int; 2007 Oct; 27(12):1185-6. PubMed ID: 17252260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum levels of chitotriosidase as a marker of disease activity and clinical stage in sarcoidosis.
    Grosso S; Margollicci MA; Bargagli E; Buccoliero QR; Perrone A; Galimberti D; Morgese G; Balestri P; Rottoli P
    Scand J Clin Lab Invest; 2004; 64(1):57-62. PubMed ID: 15025429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Biomarkers of Sarcoidosis: A Comparative Study of Serum Chitotriosidase, ACE, Lysozyme, and KL-6.
    Bergantini L; Bianchi F; Cameli P; Mazzei MA; Fui A; Sestini P; Rottoli P; Bargagli E
    Dis Markers; 2019; 2019():8565423. PubMed ID: 30944672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ACE and sIL-2R correlate with lung function improvement in sarcoidosis during methotrexate therapy.
    Vorselaars AD; van Moorsel CH; Zanen P; Ruven HJ; Claessen AM; van Velzen-Blad H; Grutters JC
    Respir Med; 2015 Feb; 109(2):279-85. PubMed ID: 25496652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum chitotriosidase activity in sarcoidosis patients.
    Bargagli E; Rottoli P
    Rheumatol Int; 2007 Oct; 27(12):1187. PubMed ID: 17710404
    [No Abstract]   [Full Text] [Related]  

  • 11. The Role of Urinary Calcium and Chitotriosidase in a Cohort of Chronic Sarcoidosis Patients.
    Cameli P; Gonnelli S; Bargagli E; d'Alessandro M; Bergantini L; Favetta V; Tomai Pitinca MD; Lisi E; Refini RM; Pieroni M; Sestini P; Caffarelli C
    Respiration; 2020; 99(3):207-212. PubMed ID: 32114588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chitotriosidase activity in sarcoidosis and some other pulmonary diseases.
    Tercelj M; Salobir B; Simcic S; Wraber B; Zupancic M; Rylander R
    Scand J Clin Lab Invest; 2009; 69(5):575-8. PubMed ID: 19347743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human chitotriosidase: a sensitive biomarker of sarcoidosis.
    Bargagli E; Bennett D; Maggiorelli C; Di Sipio P; Margollicci M; Bianchi N; Rottoli P
    J Clin Immunol; 2013 Jan; 33(1):264-70. PubMed ID: 22878841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-2 Receptor and Angiotensin-Converting Enzyme as Markers for Ocular Sarcoidosis.
    Gundlach E; Hoffmann MM; Prasse A; Heinzelmann S; Ness T
    PLoS One; 2016; 11(1):e0147258. PubMed ID: 26799486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. YKL-40, Soluble IL-2 Receptor, Angiotensin Converting Enzyme and C-Reactive Protein: Comparison of Markers of Sarcoidosis Activity.
    Uysal P; Durmus S; Sozer V; Gelisgen R; Seyhan EC; Erdenen F; Simsek G; Uzun H
    Biomolecules; 2018 Aug; 8(3):. PubMed ID: 30154391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimized angiotensin-converting enzyme activity assay for the accurate diagnosis of sarcoidosis.
    Csongrádi A; Enyedi A; Takács I; Végh T; Mányiné IS; Pólik Z; Altorjay IT; Balla J; Balla G; Édes I; Kappelmayer J; Tóth A; Papp Z; Fagyas M
    Clin Chem Lab Med; 2018 Jun; 56(7):1117-1125. PubMed ID: 29425104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma chitotriosidase and CCL18 as surrogate markers for granulomatous macrophages in sarcoidosis.
    Boot RG; Hollak CE; Verhoek M; Alberts C; Jonkers RE; Aerts JM
    Clin Chim Acta; 2010 Jan; 411(1-2):31-6. PubMed ID: 19808030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Active Sarcoidosis Using Chitotriosidase and Angiotensin-Converting Enzyme.
    Lopes MC; Amadeu TP; Ribeiro-Alves M; da Costa CH; Rodrigues LS; Bessa EJC; Bruno LP; Lopes AJ; Rufino R
    Lung; 2019 Jun; 197(3):295-302. PubMed ID: 30888491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The usefulness of serum angiotensin-converting enzyme test in the diagnosis of sarcoidosis.
    Podwysocki B; Skowron-Szlósarczyk S; Zwoliński J; Szklarz E; Jankowska E; Masiak M
    Mater Med Pol; 1991; 23(2):121-4. PubMed ID: 1668804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extreme elevation of serum angiotensin-converting enzyme (ACE) activity: always consider familial ACE hyperactivity.
    Stouten K; van de Werken M; Tchetverikov I; Saboerali M; Vermeer HJ; Castel R; Verheijen FM
    Ann Clin Biochem; 2014 Mar; 51(Pt 2):289-93. PubMed ID: 23897103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.